Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
RESEARCH TOOLSreports
Holding TAK?
Track your performance easily
TAK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.58 - $15.08
Previous Close$13.65
Volume1.00M
Average Volume (3M)1.65M
Market Cap
$43.15B
Enterprise Value$71.64B
Total Cash (Recent Filing)¥457.80B
Total Debt (Recent Filing)¥4.84T
Price to Earnings (P/E)22.3
Beta0.26
Next Earnings
Jan 30, 2025EPS Estimate
$0.11Last Dividend Ex-Date
Sep 30, 2024Dividend Yield4.6%
Share Statistics
EPS (TTM)0.61
Shares Outstanding3,138,026,928
10 Day Avg. Volume1,140,772
30 Day Avg. Volume1,653,675
Standard Deviation0.07
R-Squared0.17
Alpha-0.00491
Financial Highlights & Ratios
Price to Book (P/B)0.00600
Price to Sales (P/S)1.44
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$14.80Price Target Upside9.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Takeda Pharmaceutical Company News
PremiumCompany Announcements
Takeda Pharmaceutical Announces Robust Earnings Growth
PremiumPre-Earnings
Is TAK a Buy, Before Earnings?
Ownership Overview
―
Insiders
0.43% Mutual Funds
0.35% Other Institutional Investors
99.01% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TAK FAQ
What was Takeda Pharmaceutical Company’s price range in the past 12 months?
Takeda Pharmaceutical Company lowest stock price was $12.57 and its highest was $15.08 in the past 12 months.
What is Takeda Pharmaceutical Company’s market cap?
Currently, no data Available
When is Takeda Pharmaceutical Company’s upcoming earnings report date?
Takeda Pharmaceutical Company’s upcoming earnings report date is Jan 30, 2025 which is in 70 days.
How were Takeda Pharmaceutical Company’s earnings last quarter?
Takeda Pharmaceutical Company released its earnings results on Oct 31, 2024. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.124 by $0.066.
Is Takeda Pharmaceutical Company overvalued?
According to Wall Street analysts Takeda Pharmaceutical Company’s price is currently Undervalued.
Does Takeda Pharmaceutical Company pay dividends?
Takeda Pharmaceutical Company pays a Semiannually dividend of $0.33 which represents an annual dividend yield of 4.6%. See more information on Takeda Pharmaceutical Company dividends here
What is Takeda Pharmaceutical Company’s EPS estimate?
Takeda Pharmaceutical Company’s EPS estimate is $0.11.
How many shares outstanding does Takeda Pharmaceutical Company have?
Takeda Pharmaceutical Company has 3,181,875,200 shares outstanding.
What happened to Takeda Pharmaceutical Company’s price movement after its last earnings report?
Takeda Pharmaceutical Company reported an EPS of $0.19 in its last earnings report, beating expectations of $0.124. Following the earnings report the stock price went up 0.36%.
Which hedge fund is a major shareholder of Takeda Pharmaceutical Company?
Among the largest hedge funds holding Takeda Pharmaceutical Company’s share is Brandes Investment Partners LP. It holds Takeda Pharmaceutical Company’s shares valued at 34M.
---
Takeda Pharmaceutical Company Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.80 (9.31% Upside)
$14.80 (9.31% Upside)
Blogger Sentiment
Bullish
TAK Sentiment 80%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 188.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.4%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.29%
12-Months-Change
Fundamentals
Return on Equity
4.02%
Trailing 12-Months
Asset Growth
2.23%
Trailing 12-Months
Company Description
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited is engaged in the research and development, manufacturing, marketing, and importing and exporting of pharmaceutical drugs and other healthcare products. The company offers pharmaceutical products in the areas of oncology, neuroscience, gastroenterology, and rare diseases.
---
TAK Company Deck
---
TAK Earnings Call
Q2 2024
0:00 / 0:00
---
TAK Stock 12 Month Forecast
Average Price Target
$14.80
▲(9.31% Upside)
Technical Analysis
Best Analysts Covering TAK
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-1.18%
reiterated a buy rating 20 days ago
Copying Michael Nedelcovych's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -1.18% per trade.
---